These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

427 related items for PubMed ID: 20686427

  • 21. [Problems in measuring parameters of the fibrinolytic system: circadian rhythm of tissue-type plasminogen activator and plasminogen activator inhibitor].
    Köhler M, Miyashita C.
    Klin Wochenschr; 1988; 66 Suppl 12():62-7. PubMed ID: 3126347
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Activation of both coagulation and fibrinolysis in childhood hemolytic uremic syndrome.
    Van Geet C, Proesmans W, Arnout J, Vermylen J, Declerck PJ.
    Kidney Int; 1998 Oct; 54(4):1324-30. PubMed ID: 9767551
    [Abstract] [Full Text] [Related]

  • 25. Behaviour of tissue plasminogen activator, plasminogen activator inhibitor 1 and their complex in various disease states.
    Niwano H, Takahashi H, Tatewaki W, Wada K, Seki Y, Shibata A.
    Blood Coagul Fibrinolysis; 1992 Aug; 3(4):389-93. PubMed ID: 1420814
    [Abstract] [Full Text] [Related]

  • 26. [Decreased fibrinolytic capacity in coronary patients by increased plasminogen activator inhibitor activity].
    Ihnken K, Speiser W, Müller-Berghaus G, Beyersdorf F, Schlepper M, Satter P.
    Helv Chir Acta; 1992 Jan; 58(4):503-8. PubMed ID: 1582860
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Sex differences in the determinants of fibrinolytic activity.
    MacCallum PK, Cooper JA, Howarth DJ, Meade TW, Miller GJ.
    Thromb Haemost; 1998 Mar; 79(3):587-90. PubMed ID: 9531046
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Fluctuations of tissue-type plasminogen activator.plasminogen activator inhibitor-1 complex in patients with DIC].
    Nagaizumi K, Kuroso K, Amano K, Sato T, Fukutake K, Fujimaki M.
    Rinsho Byori; 1994 Jul; 42(7):707-12. PubMed ID: 8065036
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. The fibrinolytic system in chronic renal failure.
    Lottermoser K, Petras S, Pöge U, Fimmers R, Hertfelder HJ, Schiermeyer B, Vetter H, Düsing R.
    Eur J Med Res; 2001 Sep 28; 6(9):372-6. PubMed ID: 11591527
    [Abstract] [Full Text] [Related]

  • 37. The fibrinolytic system in the hemolytic uremic syndrome: in vivo and in vitro studies.
    van de Kar NC, van Hinsbergh VW, Brommer EJ, Monnens LA.
    Pediatr Res; 1994 Aug 28; 36(2):257-64. PubMed ID: 7970942
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Activation of fibrinolytic pathways is associated with duration of supraceliac aortic cross-clamping.
    Haithcock BE, Shepard AD, Raman SB, Conrad MF, Pandurangi K, Fanous NH.
    J Vasc Surg; 2004 Aug 28; 40(2):325-33. PubMed ID: 15297829
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.